0 Replies
LAKE OSWEGO, Ore., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled, "Cancer Vaccine... Contine Reading & Discuss→
0 Replies
NeuVax adjuvant therapy intended for patients not eligible for Herceptin® (trastuzumab) therapyPhase 3 trial being conducted under FDA-approved Special Protocol Assessment; initiated ahead of schedule
LAKE OSWEGO, Jan. 20, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced the... Contine Reading & Discuss→